Condition 1: Metabolic Syndrome. Condition 2: Obesity. Metabolic syndrome Obesity due to excess calories
Conditions
Interventions
Intervention 1: Intervention group: Functional cake group containing oak powder.The caloric content of both oak and wheat cakes will be equal, so due to the higher calorie content of oak flour, 10 gra
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age range 20 to 60 years Body mass index (BMI) of 25–35 kg/m2 According to the ATP III definition, metabolic syndrome is present if three or more of the following five criteria are met: waist circumference over 102 cm (men) or 88 cm (women), blood pressure over 130/85 mmHg, fasting triglyceride (TG) level over 150 mg/dl, fasting high-density lipoprotein (HDL) cholesterol level less than 40 mg/dl (men) or 50 mg/dl (women) and fasting blood sugar over 100 mg/dl Stable body weight (weight change less than 3 kg in the last 3 months) Not participating in weight loss programs for the past 6 months
Exclusion criteria
Exclusion criteria: Diabetic patients receiving blood sugar-lowering drugs and insulin History of alcohol consumption Smoking Pregnant and lactating women People with mental illness, cancer, thyroid, cardiovascular, pulmonary, renal, hepatic, eating disorders Taking drugs that affect appetite, body weight and lipid metabolism or have anti-inflammatory effect
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anthropometric measures. Timepoint: Before and after the intervention. Method of measurement: Bioelectric impedance analysis.;Blood pressure. Timepoint: Before and after the intervention. Method of measurement: digital sphygmomanometer.;Fasting blood sugar. Timepoint: Before and after the intervention. Method of measurement: Commercial kits.;Insulin. Timepoint: Before and after the intervention. Method of measurement: ELISA kit.;Insulin resistance index (HOMA-IR). Timepoint: Before and after the intervention. Method of measurement: Formula.;Lipids profile. Timepoint: Before and after the intervention. Method of measurement: Commercial kits.;Malon de aldehyde (MDA). Timepoint: Before and after the intervention. Method of measurement: Tubarbitoric acid method (TBARS).;C-reactive protein. Timepoint: Before and after the intervention. Method of measurement: ELISA kit.;Adiponectin. Timepoint: Before and after the intervention. Method of measurement: ELISA kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Mohamadi
Shiraz University of Medical Sciences
Outcome results
None listed